Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Hydroxypropyl Methyl Cellulose

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2NICORETTE

    02 2NICORETTE (MINT)

    03 1NICOTINE POLACRILEX

    04 1ORAVIG

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    GALT PHARMS

    MICONAZOLE

    arrow
    ASPEN
    Not Confirmed
    GALT PHARMS
    U.S.A
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MICONAZOLE

    Drug : ORAVIG

    Dosage Form : TABLET; BUCCAL

    Application Number : 22404

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    HALEON US HOLDINGS

    NICOTINE POLACRILEX

    arrow
    ASPEN
    Not Confirmed
    HALEON US HOLDINGS
    United Kingdom
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    NICOTINE POLACRILEX

    Drug : NICORETTE (MINT)

    Dosage Form : GUM, CHEWING; BUCCAL

    Application Number : 20066

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    HALEON US HOLDINGS

    NICOTINE POLACRILEX

    arrow
    ASPEN
    Not Confirmed
    HALEON US HOLDINGS
    United Kingdom
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    NICOTINE POLACRILEX

    Drug : NICORETTE

    Dosage Form : GUM, CHEWING; BUCCAL

    Application Number : 20066

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    HALEON US HOLDINGS

    NICOTINE POLACRILEX

    arrow
    ASPEN
    Not Confirmed
    HALEON US HOLDINGS
    United Kingdom
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    NICOTINE POLACRILEX

    Drug : NICORETTE (MINT)

    Dosage Form : GUM, CHEWING; BUCCAL

    Application Number : 18612

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    HALEON US HOLDINGS

    NICOTINE POLACRILEX

    arrow
    ASPEN
    Not Confirmed
    HALEON US HOLDINGS
    United Kingdom
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    NICOTINE POLACRILEX

    Drug : NICORETTE

    Dosage Form : GUM, CHEWING; BUCCAL

    Application Number : 18612

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    P AND L

    NICOTINE POLACRILEX

    arrow
    ASPEN
    Not Confirmed
    P AND L
    U.S.A
    arrow
    ASPEN
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    NICOTINE POLACRILEX

    Drug : NICOTINE POLACRILEX

    Dosage Form : GUM, CHEWING; BUCCAL

    Application Number : 79219

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.